2,357
Views
15
CrossRef citations to date
0
Altmetric
Review

Theory and strategy for Pneumococcal vaccines in the elderly

, , , , , , , , , , , & show all
Pages 336-343 | Received 14 Apr 2015, Accepted 19 Jul 2015, Published online: 23 Feb 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Koji Kuronuma & Hiroki Takahashi. (2019) Immunogenicity of pneumococcal vaccines in comorbid autoimmune and chronic respiratory diseases. Human Vaccines & Immunotherapeutics 15:4, pages 859-862.
Read now
A. T. Newall. (2016) What do we know about the cost-effectiveness of pneumococcal conjugate vaccination in older adults?. Human Vaccines & Immunotherapeutics 12:10, pages 2666-2669.
Read now

Articles from other publishers (13)

Eduardo Willian de Alencar Pereira, Valéria Costa Fontes, Erika Alves da Fonseca Amorim, Rita de Cássia Mendonça de Miranda, Rafael Cardoso Carvalho, Eduardo Martins de Sousa, Susanne Carolinne Penha Ferreira Cutrim, Claudia Zeneida G.P. Alves Lima, Andrea de Souza Monteiro & Lidio Gonçalves Lima Neto. (2023) Antimicrobial effect of quercetin against Streptococcus pneumoniae. Microbial Pathogenesis 180, pages 106119.
Crossref
Noriko MATSUMOTOMasayuki OHKURABennett LEETomoyuki HAYAMIZU. (2022) Safety of A Pneumococcal 13-valent Conjugate Vaccine in Elderly Japanese Patients in Daily Practice: Results of A Drug Use-Results Survey高齢者に対する沈降13価肺炎球菌結合型ワクチンの日常診療下における安全性評価―使用成績調査―. Kansenshogaku Zasshi 96:1, pages 15-24.
Crossref
Ying Yang, Chun-Zhen Hua, Chao Fang, Yong-Ping Xie, Wei Li, Yong Fu, Feng Gao & Kai-Hu Yao. (2021) Properties of Mucoid Serotype 3 Streptococcus pneumoniae From Children in China. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Lina Reslan, Marc Finianos, Ibrahim Bitar, Mohamad Bahij Moumneh, George F. Araj, Alissar Zaghlout, Celina Boutros, Tamima Jisr, Malak Nabulsi, Gilbert Kara yaccoub, Monzer Hamze, Marwan Osman, Elie Bou Raad, Jaroslav Hrabak, Ghassan M. Matar & Ghassan Dbaibo. (2021) The Emergence of Invasive Streptococcus pneumoniae Serotype 24F in Lebanon: Complete Genome Sequencing Reveals High Virulence and Antimicrobial Resistance Characteristics. Frontiers in Microbiology 12.
Crossref
Ekaterina A. Kurbatova, Nelli K. Akhmatova, Anton E. Zaytsev, Elina A. Akhmatova, Nadezhda B. Egorova, Natalya E. Yastrebova, Elena V. Sukhova, Dmitriy V. Yashunsky, Yury E. Tsvetkov & Nikolay E. Nifantiev. (2020) Higher Cytokine and Opsonizing Antibody Production Induced by Bovine Serum Albumin (BSA)-Conjugated Tetrasaccharide Related to Streptococcus pneumoniae Type 3 Capsular Polysaccharide. Frontiers in Immunology 11.
Crossref
So Hyun Kim, Doo Ryeon Chung, Jae-Hoon Song, Jin Yang Baek, Visanu Thamlikitkul, Hui Wang, Celia Carlos, Norazah Ahmad, Revathy Arushothy, Si Huei Tan, David Lye, Cheol-In Kang, Kwan Soo Ko & Kyong Ran Peck. (2020) Changes in serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates from adult patients in Asia: Emergence of drug-resistant non-vaccine serotypes. Vaccine 38:38, pages 6065-6073.
Crossref
Gabriela Moreno & Rodolfo Villena. (2020) Vacunas en salud laboral… una oportunidad para prevenir e invertir en salud. Revista Médica Clínica Las Condes 31:3, pages 287-303.
Crossref
A. E. Zaitsev, E. A. Kurbatova, N. B. Egorova, E. V. Sukhova & N. E. Nifantiev. (2020) Immunological and Epidemiological Aspects of the Immunogenicity of Streptococcus Pneumoniae Serotype 3 Capsular Polysaccharide in Pneumococcal Vaccines. Journal of microbiology, epidemiology and immunobiology 97:1, pages 72-82.
Crossref
A. E. Zaitsev, E. A. Kurbatova, N. B. Egorova, E. V. Sukhova & N. E. Nifantiev. (2020) Immunological and Epidemiological Aspects of the Immunogenicity of Streptococcus Pneumoniae Serotype 3 Capsular Polysaccharide in Pneumococcal Vaccines. Journal of microbiology epidemiology immunobiology:1, pages 72-82.
Crossref
C. Raina MacIntyre, Iman Ridda, Mallory J. Trent & Peter McIntyre. (2019) Persistence of immunity to conjugate and polysaccharide pneumococcal vaccines in frail, hospitalised older adults in long-term follow up. Vaccine 37:35, pages 5016-5024.
Crossref
Koji Kuronuma, Hiroyuki Honda, Tessei Mikami, Atsushi Saito, Kimiyuki Ikeda, Mitsuo Otsuka, Hirofumi Chiba, Gen Yamada, Toyotaka Sato, Shin-ichi Yokota & Hiroki Takahashi. (2018) Response to pneumococcal vaccine in interstitial lung disease patients: Influence of systemic immunosuppressive treatment. Vaccine 36:33, pages 4968-4972.
Crossref
Naomi Sugimoto, Yuka Yamagishi, Jun Hirai, Daisuke Sakanashi, Hiroyuki Suematsu, Naoya Nishiyama, Yusuke Koizumi & Hiroshige Mikamo. (2017) Invasive pneumococcal disease caused by mucoid serotype 3 Streptococcus pneumoniae: a case report and literature review. BMC Research Notes 10:1.
Crossref
Kosuke Kataoka, Yoshiko Fukuyama, David E. Briles, Tatsuro Miyake & Kohtaro Fujihashi. (2017) Dendritic cell-targeting DNA-based nasal adjuvants for protective mucosal immunity to Streptococcus pneumoniae . Microbiology and Immunology 61:6, pages 195-205.
Crossref